Will medical technology issues land on MHRA (Medicines & Healthcare Products Regulatory Agency) pharmaceutical agenda?
This article was originally published in Clinica
Executive Summary
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) is to set up an advisory panel and a forum to discuss the future of regulation for pharmaceuticals. This move opens up a door for the possible discussion of issues on the drug/device borderline.